Method of regulating plasma lipoproteins
AssigneeMcMaster University
InventorShirya Rashid
Life of this patent
Estimating the term…
Abstract
A method of modulating the level of lipoproteins in human cells comprising the step of inhibiting resistin in the cells or cellular environment. The method is useful to treat cardiovascular disease.
Claims17
A method of modulating the level of lipoproteins in human cells comprising the step of inhibiting resistin within the cellular environment.
A method of screening candidate resistin inhibiting compounds comprising the steps of:
- a) incubating a candidate compound with resistin-expressing sample;
- and
- b) measuring the activity of resistin in the sample, wherein a reduction in the activity of resistin in the sample in comparison to a control value obtained in the absence of incubation with the candidate indicates that the candidate compound is a resistin inhibitor.
A method of diagnosing elevated lipoprotein levels in a human subject comprising the step of determining in a resistin-expressing sample obtained from the subject the level or activity of resistin, PCSK9 or MTP, wherein an increase in the level or activity of resistin, PCSK9 or MTP in comparison to a control level is indicative of elevated lipoprotein levels.
Dependencies are inferred from the claim text.